Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

The relationship between tumour necrosis factor-alpha (TNF-α) and drug survival had not been studied in juvenile idiopathic arthritis (JIA) and there were no laboratory tests to predict the long-term efficacy of biological drugs for JIA. We studied if serum levels of TNF-α, free or bound to etanercept, could predict long-term efficacy of etanercept in children with JIA.

Detaljer

Författare
Enheter & grupper
Externa organisationer
  • Lund University
  • Skåne University Hospital
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Reumatologi och inflammation
  • Pediatrik
Originalspråkengelska
Sidor (från-till)427-432
TidskriftActa paediatrica
Volym105
Utgivningsnummer4
Tidigt onlinedatum2015 dec 27
StatusPublished - 2016
PublikationskategoriForskning
Peer review utfördJa